Folic acid, methylation and neural tube closure in humans
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
This review provides a brief description of folate use and folic acid metabolism in relation to neural tube defect (NTD) risk. First, a meta‐analysis of reduction in NTD recurrence and occurrence risk with periconceptional folic acid supplementation is presented. Second, an overview of the complex folate metabolism is given. Third, SNPs for genes involved in folate and homocysteine metabolism that have been studied in relation to NTD riskare discussed. Fourth, the questions whether folate receptor autoantibodies or hampered methylation are mechanisms underlying NTDs are briefly discussed. Birth Defects Research (Part A), 2009. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“The observation that inactivation of the DNA methyltransferase DNMT3B disrupts de novo DNA methylation and causes multiple developmental defects, including NTDs in mice, further underlines the importance of DNA methylation in relation to NTDs (Okano et al., 1999).”
BackgroundPrevention of neural tube defects: Results of the Medical Research Council Vitamin Study
(1991) · The Lancet · doi:10.1016/0140-6736(91)90133-a · Cited by 3,472
Epigenetic Reprogramming in Mammalian Development
Reik, W., Dean, W., & Walter, J. (2001) · Science · doi:10.1126/science.1063443 · Cited by 3,078 · cited 1×
“DNA methylation is reprogrammed during early embryogenesis (Reik et al., 2001), is part of the epigenetic code, is the chief regulator of gene expression 298 BLOM ET AL.”
BackgroundQiu, A., Jansen, M., Sakaris, A., Min, S. H., Chattopadhyay, S., Tsai, E., Sandoval, C., Zhao, R., Akabas, M. H., & Goldman, I. D. (2006) · Cell · doi:10.1016/j.cell.2006.09.041 · Cited by 847
Neural tube defects and folate: case far from closed
Blom, H. J., Shaw, G. M., den Heijer, M., & Finnell, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1986 · Cited by 562 · cited 6×
“Notably, in several monogenic mouse mutants that have NTDs with no obvious connection to folate metabolism, NTDs are prevented by the use of folic acid (Blom et al., 2006).”
BackgroundInfluentialSelf-citation
Cited by
Blom, H. J., & Smulders, Y. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9177-4 · Cited by 454
Self-citationSchmidt, R. J., Tancredi, D. J., Ozonoff, S., Hansen, R. L., Hartiala, J., Allayee, H., Schmidt, L. C., Tassone, F., & Hertz-Picciotto, I. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004416 · Cited by 408
“The epigenetic effect of methyl metabolism is a mechanism proposed for the prevention of NTDs through periconceptional folic acid supplementation (53) and is TABLE 4”
BackgroundEpidemiologic and genetic aspects of spina bifida and other neural tube defects
Au, K. S., Ashley‐Koch, A., & Northrup, H. (2010) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.93 · Cited by 344
Harris, M. J., & Juriloff, D. M. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20676 · Cited by 335
Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism
Schmidt, R. J., Hansen, R. L., Hartiala, J., Allayee, H., Schmidt, L. C., Tancredi, D. J., Tassone, F., & Hertz-Picciotto, I. (2011) · Epidemiology · doi:10.1097/ede.0b013e31821d0e30 · Cited by 308
“Hispanic 82 (28) 82 (30) 60 (25) 66 (28)”
Mandy, W., & Lai, M. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12501 · Cited by 283
“Conversely, supplementation of a mother’s diet at the start of pregnancy with folic acid, a synthetic form of folate, reduces the risk of NTD and improves cognitive outcomes for offspring (Veena et al., 2010; Wolff, Witkop, Miller, & Syed, 2009).”
BackgroundInfluentialNeural Tube Defects, Folic Acid and Methylation
Imbard, A., Benoist, J.-F., & Blom, H. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10094352 · Cited by 281
Self-citationPreconception care: nutritional risks and interventions
Dean, S. V., Lassi, Z. S., Imam, A. M., & Bhutta, Z. A. (2014) · Reproductive Health · doi:10.1186/1742-4755-11-s3-s3 · Cited by 279
“Other meta-analyses of randomized and observational studies showed a reduction in recurrence risk of 69 to 100% [38] and a reduction in occurrence risk of 42 [39] to 62% [40], yet less than half of all women regularly consume folic acid before conception [41].”
Wilson, R. D., Wilson, R. D., Audibert, F., Brock, J.-A., Carroll, J., Cartier, L., Gagnon, A., Johnson, J.-A., Langlois, S., Murphy-Kaulbeck, L., et al. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30230-9 · Cited by 259
The Controversial Role of Homocysteine in Neurology: From Labs to Clinical Practice
Moretti, R., & Caruso, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010231 · Cited by 248
Lacasaña, M., Blanco-Muñoz, J., Borja-Aburto, V. H., Aguilar-Garduño, C., Rodríguez-Barranco, M., Sierra-Ramirez, J. A., Galaviz-Hernandez, C., Gonzalez-Alzaga, B., & Garcia-Cavazos, R. (2012) · Public Health Nutrition · doi:10.1017/s136898001100334x · Cited by 29
“Human and animal studies have shown that the cause of NTD is multifactorial and that folate metabolism, although important, is not the only factor((49)).”
Background
Metadata
- Authors
- Blom, H. J.
- Venue
- Birth Defects Research Part A: Clinical and Molecular Teratology
- Publisher
- Wiley
- Published
- 2009-03-19
- Volume
- 85
- Issue
- 4
- Pages
- 295-302
- ISSN
- 1542-0752 (ISSN-L)
- 1542-0760
- OpenAlex
- W2054437476
- Cited by
- 135
- References
- 5
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.